Header Logo

Connection

SUSAN BLANEY to Tumor Burden

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Tumor Burden.
SUSAN BLANEY
Connection Strength
0.020
Tumor Burden
  1. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res. 2010 Jan 15; 16(2):750-4.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.